AgMedica appoints business development lead for tissue culture / plant propagation business

AgMedica is a vertically integrated biotech company dedicated to becoming a global leader in the development and commercialization of cannabis and cannabis-derived products that can support the health and wellness of its own clients, as well as other organizations. 

In helping further this goal, the company recently appointed Mr. Gregory Gawne as Senior Vice President, Business Development to grow new business opportunities horizontally across the company’s supply chain. In particular,  AgMedica is developing a stand-alone facility in Chatham, Ontario dedicated to the propagation of cannabis, which the company believes will fill a significant void in the cannabis industry. Once fully completed, the state-of-the-art tissue culture facility will have the capacity to produce for AgMedica’s own cultivation needs as well as other third-party licensed cultivators around the world.

Most recently, as Vice President, Operations for AgMedica, Gregory gained a strong understanding of the industry. In his new role, Gregory will leverage this and his more than 35 years of sales strategy, business development and leadership experience with diversified industries across North America and Europe, to build and grow this highly promising segment of AgMedica’s business. Gregory has a strong track record for building high growth network developments, and a passion for break-throughs and industry firsts. Both he and the Company look forward to bringing exciting and innovative partnership solutions to the global cannabis industry.

Based out of Chatham, Ontario, AgMedica Bioscience now has five facilities under development along its vertical, from propagation to cultivation to processing. AgMedica has become a global company with strategic relationships and value-add partnerships in Germany, Italy, Israel, Spain and Portugal. The company aspires to drive the evolution of the cannabis industry by focussing investment on the development and commercialization of differentiated products in the medicinal, health & wellness and pharmaceutical sectors.

For more information:
AgMedica Bioscience
M. Gregory Gawne
Senior Vice President, Business Development
T: 1-844-247-4633 ext. 106

Publication date:

Receive the daily newsletter in your email for free | Click here

Other news in this sector:

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.

Click here for a guide on disabling your adblocker.